Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

Inclusion Criteria

• •1. Presenting (in person or via telemedicine) for evaluation because they:
• •* Have clinical symptoms consistent with for COVID-19:
• •* Fever (≥ 37.8 °C) on examination OR patient reported fever (≥ 37.8 °C) or feverishness (felt febrile but did not take temperature) OR any of, cough, sore throat, shortness of breath, rhinorrhoea, headache, chills, generalise myalgia, malaise, fatigue, confusion, diarrhea, nausea or vomiting
• •* Have been contacted because they have been identified as a contact to a confirmed case
• •* Have been contacted and told they tested positive for COVID-19
• •2. Have one of the following conditions affecting immune function:
• •* Known or suspected primary immunodeficiency, defined as a predisposition to infection associated with an apparent or presumed deficit of immune function
• •* On immunosuppressive therapy
• •* Treatment with immune checkpoint inhibitors within 36 months of enrolment date
• •* HIV infection
• •* Diagnosis of cancer within 36 months of enrolment date, excluding superficial basal cell and squamous cell carcinomas
• •* Solid organ transplantation
• •3. For optional biobanking only, ability to provide informed consent